Veratraldehyde → 1-Butyl-6-methyl-3-[3,4-dimethoxyphenyl]-1H-pyrimido[5,4-e][1,2,4]triazine-5,7-dione
Reaktionsgleichung
[CH2:1]([N:5]1[C:10]2=[N:11][C:12](=[O:17])[N:13]([CH3:16])[C:14](=[O:15])[C:9]2=[N:8][C:7]([C:18]2[CH:23]=[CH:22][CH:21]=[C:20]([O:24][C:25]3C=CC=CC=3)[CH:19]=2)=[N:6]1)[CH2:2][CH2:3][CH3:4].[CH3:31][O:32]C1C=C(C=CC=1OC)C=O>>[CH2:1]([N:5]1[C:10]2=[N:11][C:12](=[O:17])[N:13]([CH3:16])[C:14](=[O:15])[C:9]2=[N:8][C:7]([C:18]2[CH:23]=[CH:22][C:21]([O:32][CH3:31])=[C:20]([O:24][CH3:25])[CH:19]=2)=[N:6]1)[CH2:2][CH2:3][CH3:4]Komponenten
3
Versuchsvorschrift
Compound 21 is prepared, as described in 4, by reacting the hydrazine 20 (176 mg, 0.54 mmol) with 3,4-dimethoxybenzaldehyde (88 mg, 0.54 mmol).
Quellen und Nachweise
- ORD-Eintrag
- ord-414afab28b844d7f9885816e387567b4
- Quelldatensatz
- uspto-grants-2010_06